您现在的位置是:幻浪视界 > 休闲
Weight regain happens 4x faster after stopping GLP
幻浪视界2026-02-01 04:22:02【休闲】4人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(74)
相关文章
- 芬兰户外运动品牌ICEPEAK全新“Amuse in Arctic 极地 • 驭雪”雪服系列
- เขตรักษาพันธุ์สัตว์ป่าเขาอ่างฤาไน ระดมกำลังใน 6 จังหวัด เฝ้าระวังช้างป่าเข้มข้นตลอด 24 ชั่วโมง
- dnf手游DIY雪人套活动如何操作 DIY雪人套玩法介绍
- 帕南原型直播《赛博朋克2077》 亲热剧情被父母撞见
- 《白银之城》开启封闭B测招募 虚幻5开放世界ARPG
- 王心凌演唱会发生意外,部分演出取消
- 李昊回应:没有虽败犹荣
- 蜀山区稻香村街道:在周末,把烦心事聊成暖心事
- “成都女子家门口遇害案”一审判处被告人死刑 缓期二年执行
- Greer dismisses world leaders' criticism of Trump at Davos summit
站长推荐
友情链接
- 昆仑万维发布Mureka V8音乐大模型,多维性能超Suno
- 《怪奇物语》片场趣事:麦克斯是公认的《马车》高手
- 安徽:让志愿服务“热在当下”“暖在日常”
- 中新网评:敢搞抽奖的品牌,别玩文字游戏
- 原神4.5版本千织岩属性角色培养一图流 原神千织培养攻略
- 《逃出从此以后》PC版下载 Steam正版分流下载
- 亮点和挑战并存——访米兰冬奥会中国体育代表团秘书长王磊
- 九牧之野新赛季战械玩法机制一览
- 崩坏星穹铁道2.0纯色量子队培养推荐 崩坏星穹铁道2.0花火适合什么队伍
- ไวรัสนิปาห์: อาการ การติดเชื้อ และสถานการณ์ระบาดในอินเดีย
- สตง.แจ้งผลตรวจอาคารถล่ม อัยการสั่งฟ้องอาญาผู้ต้องหา 23 ราย
- 住建部:指导各地加快垃圾分类管理立法工作
- 种田养鱼?豪宅别墅?在蜀境传说中打造一座个性十足的仙府!
- 一室一厅小户型装修要点 小户型装修注意什么
- 荣获中国水工业“最具影响力企业”称号
- 归龙潮街机之霸任务怎么完成 街机之霸任务玩法攻略
- 10秒离场,上海462家商场停车场推出停车缴费“纯净码”
- 竹内凉真×井上真央共演新剧《再会~沉默的真相~》首发预告 定档2026年1月
- 金平牛蒡的做法及功效
- 英雄联盟2024最年轻的世界冠军是谁 lol2024最年轻的世界冠军介绍一览







